MedPath

The Effect of Erythropoeitin on Anemia of Prematurity

Phase 2
Conditions
Anemia of Prematurity.
Anaemia of prematurity
Registration Number
IRCT201112265110N2
Lead Sponsor
Vice Chancellor for Research and Tchnology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Inclusion Criteria: Neonates with birth weight less than 1500 gram; gestational age less than 31 weeks; post natal age at Least 6 days; received calories at least 50 Kcal/kg, at Least 50% in enteral route; Hct=< 40%. Exclusion criteria: Severe congenital anomalies, dysmorphic syndromes; hemolytic anemia; severe acute infections.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eed to transfusion. Timepoint: At the end of treatment. Method of measurement: The number of transfusions.
Secondary Outcome Measures
NameTimeMethod
Hemoglobin, Hematocrit, Reticulocyte count. Timepoint: Weekly. Method of measurement: CBC.;Weight of neonate. Timepoint: weekly. Method of measurement: Seca scale.
© Copyright 2025. All Rights Reserved by MedPath